He, L. (2023). SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits. Highlights in Science, Engineering and Technology, 74, 1717-1722. https://doi.org/10.54097/m9vm2798